H3K4me3 and Wdr82 are associated with tumor progression and a favorable prognosis in human colorectal cancer

Oncology Letters
He LiuBinbin Cui

Abstract

Histone methylation is closely associated with the occurrence of cancer. Histone H3 trimethylation at lysine 4 (H3K4me3) has been reported to modulate the expression of tumor-associated expression and be altered during the progression of several human cancers. WD Repeat Domain 82 (Wdr82), a key epigenetics-associated factor, is a component of the H3K4me3 methyltransferase complex. An aim of the present study was to determine H3K4me3 and Wdr82 expression and their clinical significances in colorectal cancer (CRC). Immunohistochemistry results demonstrated that the expression level of the H3K4me3 and Wdr82 were significantly decreased in CRC tissues compared with paired noncancerous tissues from 123 patients with CRC. Furthermore, the negative expression of H3K4me3 and Wdr82 expression were significantly associated with lymph node (n=33, P=0.0001) and liver metastasis (n=30, P=0.0001). Additionally, multivariate Cox regression analysis indicated that the low expression level of H3K4me3 or Wdr82 was associated with reduced overall survival (OS, P<0.05), and patients with a low H3K4me3 and Wdr82 expression had a significantly poorer outcome compared with patients with a high expression of H3K4me3 and Wdr82 (P=0.0001), suggesting th...Continue Reading

References

Mar 6, 1998·Cellular and Molecular Life Sciences : CMLS·T JenuweinG Reuter
Mar 10, 1999·Journal of the National Cancer Institute·J S MandelJ H Bond
Dec 26, 2001·Proceedings of the National Academy of Sciences of the United States of America·Peter L NagyMichael L Cleary
Jan 24, 2002·The Journal of Biological Chemistry·Nevan J KroganAli Shilatifard
Sep 28, 2002·Nature·Helena Santos-RosaTony Kouzarides
Oct 30, 2004·Scandinavian Journal of Gastroenterology·O KronborgM Rasmussen
Jul 1, 2005·Nature·Tae Hoon KimBing Ren
Sep 9, 2006·Biochemical and Biophysical Research Communications·Seung-Kyoon KimYong Sung Kim
Mar 16, 2007·The Journal of Biological Chemistry·Jeong-Heon LeeDavid G Skalnik
Apr 7, 2007·Pediatric Research·Jian Qun Ling, Andrew R Hoffman
May 16, 2008·The American Journal of Gastroenterology·Paul HewitsonLes Irwig
Sep 10, 2009·The Prostate·Jörg EllingerAlexander von Ruecker
Feb 18, 2010·International Journal of Cancer. Journal International Du Cancer·Jörg EllingerAlexander von Ruecker
Feb 25, 2010·Annals of Surgical Oncology·Stephen B Edge, Carolyn C Compton
Jul 5, 2011·Nature Structural & Molecular Biology·Oliver G McDonaldAndrew P Feinberg
Apr 14, 2012·Science·Batool Akhtar-ZaidiPeter C Scacheri
Jul 10, 2012·Cell·Mark A Dawson, Tony Kouzarides
Mar 15, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J FerlayF Bray
Jun 14, 2013·Nature Reviews. Cancer·Winston Timp, Andrew P Feinberg
Aug 29, 2013·World Journal of Gastroenterology : WJG·Daren LowEmiko Mizoguchi
Mar 19, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Sep 24, 2015·Nature Communications·Ken TajimaShyamala Maheswaran
Oct 6, 2015·Biochemical and Biophysical Research Communications·Youyi DaiLiangfang Shen
Jan 4, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Vishal DasMintu Pal

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection
acetylation
xenograft

Software Mentioned

AlphaView

Related Concepts

Related Feeds

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.